Loading patent…
AssigneesKyoto University, Takeda Pharmaceutical Company Limited
InventorsShin Kaneko, Shoichi Iriguchi, Yuta Mishima, Yoshiaki Kassai, Akira Hayashi, Suguru Arima
Estimating the term…
Provided is a method for producing a CD4/CD8 double positive cell, including the following steps: step 1: separating, from a cell population containing a hematopoietic progenitor cell, a cell expressing one or more kinds of molecules selected from the first group consisting of CD24, CD62L, CD90, CD143, CD263, Notch3, CD32, CD39, CD49a, CD164, CD317, CD200, CD218a, CD7, CD144, CD56, CD226, CD262 and CD325, and/or a cell not expressing one or more kinds of molecules selected from the second group consisting of CD49f, CD51, CD102, CD42b, CD61, CD62P, CD69, CD102 and CD156c, and step 2: differentiating the cell separated in step 1 into a CD4/CD8 double positive cell.
A method for producing CD4/CD8 double positive cells, the method comprising
A method for producing CD8 single positive cells, the method comprising
Dependencies are inferred from the claim text.